Progress in aldosteronism: a review of the prevalence of primary aldosteronism in pre-hypertension and hypertension
G Piaditis, A Markou, L Papanastasiou… - European Journal of …, 2015 - academic.oup.com
Primary aldosteronism (PA) secondary to excessive and/or autonomous aldosterone
secretion from the renin–angiotensin system accounts for∼ 10% of cases of hypertension …
secretion from the renin–angiotensin system accounts for∼ 10% of cases of hypertension …
Common secondary causes of resistant hypertension and rational for treatment
C Faselis, M Doumas… - International journal of …, 2011 - Wiley Online Library
Resistant hypertension is defined as uncontrolled blood pressure despite the use of three
antihypertensive drugs, including a diuretic, in optimal doses. Treatment resistance can be …
antihypertensive drugs, including a diuretic, in optimal doses. Treatment resistance can be …
A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients
Objectives: We prospectively investigated the prevalence of curable forms of primary
aldosteronism (PA) in newly diagnosed hypertensive patients. Background: The prevalence …
aldosteronism (PA) in newly diagnosed hypertensive patients. Background: The prevalence …
Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study
S Douma, K Petidis, M Doumas, P Papaefthimiou… - The Lancet, 2008 - thelancet.com
Background Results of several studies published since 1999 suggest that primary
hyperaldosteronism (also known as Conn's syndrome) affects more than 10% of people with …
hyperaldosteronism (also known as Conn's syndrome) affects more than 10% of people with …
Renal damage in primary aldosteronism: results of the PAPY Study
Primary aldosteronism (PA) has been associated with cardiovascular hypertrophy and
fibrosis, in part independent of the blood pressure level, but deleterious effects on the …
fibrosis, in part independent of the blood pressure level, but deleterious effects on the …
[PDF][PDF] V Diretrizes brasileiras de hipertensão arterial
D Mion Júnior, AMG Pierin - Arquivos Brasileiros de Cardiologia, 2007 - repositorio.usp.br
Passados quatro anos, foi necessário rever as condutas diagnósticas e terapêuticas em
hipertensão arterial para publicar as V Diretrizes Brasileiras de Hipertensão Arterial e …
hipertensão arterial para publicar as V Diretrizes Brasileiras de Hipertensão Arterial e …
Prevalence and characteristics of the metabolic syndrome in primary aldosteronism
F Fallo, F Veglio, C Bertello, N Sonino… - The Journal of …, 2006 - academic.oup.com
Context: Patients with hypertension have a high prevalence of concurrent metabolic
abnormalities, including obesity, dyslipidemia, and hyperglycemia. Clustering of these …
abnormalities, including obesity, dyslipidemia, and hyperglycemia. Clustering of these …
A novel form of human mendelian hypertension featuring nonglucocorticoid-remediable aldosteronism
DS Geller, J Zhang, MV Wisgerhof… - The Journal of …, 2008 - academic.oup.com
Context: Primary aldosteronism is a leading cause of secondary hypertension (HTN), but the
mechanisms underlying the characteristic renin-independent secretion of aldosterone …
mechanisms underlying the characteristic renin-independent secretion of aldosterone …
Increased prevalence of diabetes mellitus and the metabolic syndrome in patients with primary aldosteronism of the German Conn's Registry
G Hanslik, H Wallaschofski, A Dietz… - European Journal of …, 2015 - academic.oup.com
Abstract Design Abnormalities in glucose homeostasis have been described in patients with
primary aldosteronism (PA) but most studies show inconsistent results. Therefore, we aimed …
primary aldosteronism (PA) but most studies show inconsistent results. Therefore, we aimed …
Histopathological classification of cross-sectional image–negative hyperaldosteronism
Y Yamazaki, Y Nakamura, K Omata… - The Journal of …, 2017 - academic.oup.com
Context: Approximately half of patients with primary aldosteronism (PA) have clinically
evident disease according to clinical (hypertension) and/or laboratory (aldosterone and …
evident disease according to clinical (hypertension) and/or laboratory (aldosterone and …